|
|
||||||||
Posttranslational Processing: A Novel Role Beyond Innate Immunity
Department of Antibacterials, Immunology, and Inflammation, Pfizer Global Research and Development, Pfizer, Inc., Groton, CT 06340
Human monocytes stimulated with LPS produce large quantities of
prointerleukin-1
, but little of this cytokine product is released
extracellularly as the mature biologically active species. To
demonstrate efficient proteolytic cleavage and export,
cytokine-producing cells require a secondary effector stimulus. In an
attempt to identify agents that may serve as initiators of IL-1
posttranslational processing in vivo, LPS-activated human monocytes
were treated with several individual antimicrobial peptides. Two
peptides derived from porcine neutrophils, protegrin (PTG)-1 and PTG-3,
promoted rapid and efficient release of mature IL-1
. The
PTG-mediated response engaged a mechanism similar to that initiated by
extracellular ATP acting via the P2X7 receptor. Thus, both
processes were disrupted by a caspase inhibitor, both were sensitive to
ethacrynic acid and CP-424,174, two pharmacological agents that
suppress posttranslational processing, and both were negated by
elevation of extracellular potassium. Moreover, the PTGs, like ATP,
promoted a dramatic change in monocyte morphology and a loss of
membrane latency. The PTG response was concentration dependent and was
influenced profoundly by components within the culture medium. In
contrast, porcine neutrophil antimicrobial peptides PR-26 and PR-39 did
not initiate IL-1
posttranslational processing. The human defensin
HNP-1 and the frog peptide magainin 1 elicited export of 17-kDa
IL-1
, but these agents were less efficient than PTGs. As a result of
this ability to promote release of potent proinflammatory cytokines
such as IL-1
, select antimicrobial peptides may possess important
immunomodulatory functions that extend beyond innate
immunity.
This article has been cited by other articles:
![]() |
P. Pelegrin, C. Barroso-Gutierrez, and A. Surprenant P2X7 Receptor Differentially Couples to Distinct Release Pathways for IL-1{beta} in Mouse Macrophage J. Immunol., June 1, 2008; 180(11): 7147 - 7157. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. C. K. Cheung, P. V. Turner, C. Song, D. Wu, H. Y. Cai, J. I. MacInnes, and J. Li Enhanced Resistance to Bacterial Infection in Protegrin-1 Transgenic Mice Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1812 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shi, S. Aono, W. Lu, A. J. Ouellette, X. Hu, Y. Ji, L. Wang, S. Lenz, F. W. van Ginkel, M. Liles, et al. A Novel Role for Defensins in Intestinal Homeostasis: Regulation of IL-1beta Secretion J. Immunol., July 15, 2007; 179(2): 1245 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Mitchell, M. H. Al-Haddawi, M. E. Clark, J. D. Beveridge, and J. L. Caswell Effect of Corticosteroids and Neuropeptides on the Expression of Defensins in Bovine Tracheal Epithelial Cells Infect. Immun., March 1, 2007; 75(3): 1325 - 1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Kornbluth and G. W. Stone Immunostimulatory combinations: designing the next generation of vaccine adjuvants J. Leukoc. Biol., November 1, 2006; 80(5): 1084 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pochet, S. Tandel, S. Querriere, M. Tre-Hardy, M. Garcia-Marcos, M. De Lorenzi, M. Vandenbranden, A. Marino, M. Devleeschouwer, and J.-P. Dehaye Modulation by LL-37 of the Responses of Salivary Glands to Purinergic Agonists Mol. Pharmacol., June 1, 2006; 69(6): 2037 - 2046. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yao, M. R. Karabasil, N. Purwanti, X. Li, T. Akamatsu, N. Kanamori, and K. Hosoi Tissue Kallikrein mK13 Is a Candidate Processing Enzyme for the Precursor of Interleukin-1beta in the Submandibular Gland of Mice J. Biol. Chem., March 24, 2006; 281(12): 7968 - 7976. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Verhoef, S. B. Kertesy, K. Lundberg, J. M. Kahlenberg, and G. R. Dubyak Inhibitory Effects of Chloride on the Activation of Caspase-1, IL-1{beta} Secretion, and Cytolysis by the P2X7 Receptor J. Immunol., December 1, 2005; 175(11): 7623 - 7634. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Porter, H. Yang, S. Yavagal, G. C. Preza, O. Murillo, H. Lima, S. Greene, L. Mahoozi, M. Klein-Patel, G. Diamond, et al. Distinct Defensin Profiles in Neisseria gonorrhoeae and Chlamydia trachomatis Urethritis Reveal Novel Epithelial Cell-Neutrophil Interactions Infect. Immun., August 1, 2005; 73(8): 4823 - 4833. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Verhoef, S. B. Kertesy, M. Estacion, W. P. Schilling, and G. R. Dubyak Maitotoxin Induces Biphasic Interleukin-1{beta} Secretion and Membrane Blebbing in Murine Macrophages Mol. Pharmacol., October 1, 2004; 66(4): 909 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Kahlenberg and G. R. Dubyak Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1100 - C1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Elssner, M. Duncan, M. Gavrilin, and M. D. Wewers A Novel P2X7 Receptor Activator, the Human Cathelicidin-Derived Peptide LL37, Induces IL-1{beta} Processing and Release J. Immunol., April 15, 2004; 172(8): 4987 - 4994. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Sweeney and Y. B. Kim Identification of a Novel Fc{gamma}RIIIa{alpha}-Associated Molecule That Contains Significant Homology to Porcine Cathelin J. Immunol., January 15, 2004; 172(2): 1203 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Verhoef, M. Estacion, W. Schilling, and G. R. Dubyak P2X7 Receptor-Dependent Blebbing and the Activation of Rho-Effector Kinases, Caspases, and IL-1{beta} Release J. Immunol., June 1, 2003; 170(11): 5728 - 5738. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |